Skip to main content
micro-community-banner
 
Profile Image
  • Saved

made a Post

COVID-19: FDA’s Stenzel Talks Abbott Test, Future Clearances In Call

People who test negative for COVID-19 using Abbott’s ID Now point-of-care test may need to confirm the result with a second test, a US Food and Drug Administration official said ..... see more

Source : Medtech Insight

  • Saved

made a Post

FDA Yanks Potentially Faulty COVID-19 Antibody Tests – And More May Be On The Chopping Block

The US Food and Drug Administration has yanked more than two dozen COVID-19 antibody tests after criticism they were too inaccurate to be used. The change comes after the agency ..... see more

Source : Medtech Insight

  • Saved

made a Post

What The Pandemic Can Teach Us About Running Clinical Trials

Experience during the COVID-19 pandemic should help to guide companies and regulators towards new ways of approaching clinical trials, with more use of novel study design, remote site monitoring, and ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Strides Optimistic On Prospects Of Antiviral Portfolio For COVID-19

Adopting a strategy that lives up to the tagline ‘Reset, Resurgent’ that its investor presentations begins with, Strides Pharma Science Ltd. plans to repurpose some existing medicines for ..... see more

Source : 'Scrip Intelligence'

  • Saved

made a Post

US FDA Generic Approvals Peak In April, But Annual Pace Trends Down

Generic drug approval totals peaked in April as the US Food and Drug Administration’s Office of Generic Drugs continued its teleworking output surge.Full and tentative approval totals reached their highest ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Real-World Data Partnership On COVID-19: US FDA Drawn To Consistency, Diversity of Aetion's Datasets

The US Food and Drug Administration announced a new COVID-19 real-world data partnership with Aetion this week, a collaboration that was attractive to the regulatory agency because of Aetion’s ability ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

US FDA Pushing Coronavirus Trial Sponsors To Include Control Groups

Amid the rush of coronavirus therapeutic proposals and a drive to gather data quickly, US Food and Drug Administration officials said they continue to push for development program characteristics to ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

When A Sponsor Wants To Proceed On A COVID Product, US FDA Almost Never Says No

US Food and Drug Administration officials do not appear overly interested in tamping down the unprecedented interest in finding a treatment for the coronavirus, despite the enormous workload it is ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

US False COVID-19 Claims Continue Climbing Along With Rate Of Virus’ Spread Globally

Fraudulent claims made in the US for COVID-19 treatments are growing at a rate similar to the spread of the disease itself, the Federal Trade Commission’s latest round of warning letters ..... see more

Source : 'HBW Insight'

  • Saved

made a Post

UK’s COVID-19 Track-And-Trace Confusion Persists

While the pilot program for the app that is seen as a major element in the UK’s COVID-19 surveillance effort proceeds to its planned conclusion, confusion reigns over the bigger ..... see more

Source : Medtech Insight

  • Saved

made a Post

Germany Sets COVID-19 Testing Record And Prepares For Future Outbreaks

German COVID-19 testing activity was up again last week, reaching a record 364,716 tests undertaken, 11% more than in the week before. 128 German labs are now contributing data about ..... see more

Source : Medtech Insight

  • Saved

made a Post

Novartis Oncology Head Discusses Cancer Care Challenge With COVID-19

Susanne Schaffert, president of oncology at Novartis AG, has been reflecting on the catastrophic gaps in cancer care that are resulting from the coronavirus pandemic and the challenges ..... see more

Source : 'Scrip Intelligence'

  • Saved

made a Post

WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry

An independent interim review of the World Health Organization’s handling of the coronavirus pandemic has concluded that the organization “demonstrated leadership” and made important progress in its COVID-19 response “considering ..... see more

Source : 'The Pink Sheet'

  • Saved

made a Post

Beximco Launches First Remdesivir Generic

Bangladesh's Beximco Pharma has claimed a world first after launching a generic version of remdesivir for the treatment of COVID-19. The launch in the firm’s domestic market comes after the ..... see more

Source : 'Generics Bulletin'